R278995/CRA0450, a corticotropin-releasing factor (CRF1) receptor antagonist modulates REM sleep measures in rats: Implication for therapeutic indication-Reference-Cited by-同舟云学术

R278995/CRA0450, a corticotropin-releasing factor (CRF1) receptor antagonist modulates REM sleep measures in rats: Implication for therapeutic indication

Published:2012-04 Issue:1-3 Volume:680 Page:63-68
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Ahnaou Abdallah,Steckler Thomas,Heylen Annick,Kennis Ludo,Nakazato Atsuro,Chaki Shigeyuki,Drinkenburg Wilhelmus H.I.M.

Publisher

Elsevier BV

Subject

Pharmacology

Reference48 articles.

1. Task Force on DSM-IV, Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR;American Psychiatric Association,2000

2. The hypothalamic–pituitary–adrenal axis: what can it tell us about stressors?;Armario;CNS Neurol. Disord. Drug Targets,2006

3. Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands;Bermack;Br. J. Pharmacol.,2001

4. On the interactions of the hypothalamic–pituitary–adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders;Buckley;J. Clin. Endocrinol. Metab.,2005

5. Anxiolytic-and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450;Chaki;Eur. J. Pharmacol.,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Molecular Basis of Insomnia: Implication for Therapeutic Approaches;Drug Development Research;2016-09-04

2. Evidence for the role of corticotropin-releasing factor in major depressive disorder;Neuroscience & Biobehavioral Reviews;2015-11

3. Effects of corticotropin releasing factor (CRF) on sleep and temperature following predictable controllable and uncontrollable stress in mice;Frontiers in Neuroscience;2015-07-30